Guardant Health Inc Reports Strong FourthQuarter Sales and Optimistic Outlook for 2024
Guardant Health Inc. announced impressive fourth-quarter 2023 sales of $155.1 million, a 22% increase from the previous year, exceeding expectations. ...
Tag: GH
Goldman Sachs Analyst Maintains Buy Rating on Guardant Health
On January 30, 2024, Matthew Sykes, an analyst at Goldman Sachs, continued to express his bullish sentiment on Guardant Health ...
Don't Miss It
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
